Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 20

1.

p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.

Zhang Z, Wang Y, Yao R, Li J, Lubet RA, You M.

Mol Cancer Res. 2006 Jun;4(6):401-10. Erratum in: Mol Cancer Res. 2006 Aug;4(8):599. Li, Jie [added].

2.

Use of p53 transgenic mice in the development of cancer models for multiple purposes.

Lubet RA, Zhang Z, Wiseman RW, You M.

Exp Lung Res. 2000 Dec;26(8):581-93. Review.

PMID:
11195457
3.

4-nitroquinoline-1-oxide induced experimental oral carcinogenesis.

Kanojia D, Vaidya MM.

Oral Oncol. 2006 Aug;42(7):655-67. Epub 2006 Jan 30. Review.

PMID:
16448841
4.

Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing.

Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE, Donehower LA.

Toxicol Pathol. 2001;29 Suppl:147-54. Review.

5.

Probing p53 biological functions through the use of genetically engineered mouse models.

Attardi LD, Donehower LA.

Mutat Res. 2005 Aug 25;576(1-2):4-21. Review.

PMID:
16038709
6.

Diabetes and oral oncogenesis.

Vairaktaris E, Spyridonidou S, Goutzanis L, Vylliotis A, Lazaris A, Donta I, Perrea D, Yapijakis C, Patsouris E.

Anticancer Res. 2007 Nov-Dec;27(6B):4185-93. Review.

7.

Animal models in oral cancer research.

Mognetti B, Di Carlo F, Berta GN.

Oral Oncol. 2006 May;42(5):448-60. Epub 2005 Nov 2. Review.

PMID:
16266822
8.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
9.

Mouse models dissect the role of p53 in cancer and development.

Lozano G, Liu G.

Semin Cancer Biol. 1998;8(5):337-44. Review.

PMID:
10101799
10.
11.

Nucleotide excision repair- and p53-deficient mouse models in cancer research.

Hoogervorst EM, van Steeg H, de Vries A.

Mutat Res. 2005 Jul 1;574(1-2):3-21. Epub 2005 Apr 14. Review.

PMID:
15914203
12.

A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma.

Prime SS, Thakker NS, Pring M, Guest PG, Paterson IC.

Oral Oncol. 2001 Jan;37(1):1-16. Review.

PMID:
11120478
13.

Molecular changes in oral cancer may reflect aetiology and ethnic origin.

Paterson IC, Eveson JW, Prime SS.

Eur J Cancer B Oral Oncol. 1996 May;32B(3):150-3. Review.

PMID:
8762870
14.
15.

Cancer of the oral cavity.

Chen AY, Myers JN.

Dis Mon. 2001 Jul;47(7):275-361. Review. No abstract available.

PMID:
11477373
17.

[The use of mutagenic and transgenic mice for the study of aging mechanisms and age pathology].

Anisimov VN, Alimova IN.

Adv Gerontol. 2001;7:72-94. Review. Russian.

PMID:
11582771
18.

Aging and cancer in transgenic and mutant mice.

Anisimov VN.

Front Biosci. 2003 Sep 1;8:s883-902. Review.

PMID:
12957819
19.

In vivo carcinogenesis of 4-nitroquinoline 1-oxide and related compounds.

Ito N.

Carcinog Compr Surv. 1981;6:117-53. Review. No abstract available.

PMID:
6786743
20.

Effects of p53 mutation on tumor progression: recent insights from mouse tumor models.

Donehower LA.

Biochim Biophys Acta. 1996 Mar 18;1242(3):171-6. Review. No abstract available.

PMID:
8603069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk